Alisha Nicks West, PharmD, BCPP

Pharmacists can build trust in buprenorphine care, handle early refill red flags, and point patients to resources to help them with substance use disorder.

Harm reduction for pharmacists can include person-first language and stigma-free naloxone counseling that keeps patients with substance use disorder safer.

Many patients struggle with the everyday realities of staying on the medication, which can include uncomfortable adverse effects.

The SUPPORT Act 2025 lets pharmacists prescribe buprenorphine for opioid use disorder, but DEA training and state rules shape access and new formulations.